Marjatta Sinisalo

Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy

Satu Mustjoki, Marja Ekblom, T. Petteri Arstila et al. · Leukemia · 2009 · 316 citations

Medicine, Malignant Blood Disorder, Immunology +5

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

Alemnew F. Dagnew, Osman İlhan, Won Sik Lee et al. · The Lancet Infectious Diseases · 2019 · 242 citations

Vaccination, Vaccine Safety, Vaccinology +11

Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia

Bengt Simonsson, Tobias Gedde‐Dahl, Berit Markevärn et al. · Blood · 2011 · 194 citations · Full text

Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy

H Granlund, Pekka Erkko, Marjatta Sinisalo et al. · British Journal of Dermatology · 1995 · 109 citations

Allergy Medicine, Immunology, Skin Allergy +16

Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia

Marjatta Sinisalo, Janne Aittoniemi, Petri Oivanen et al. · British Journal of Haematology · 2001 · 90 citations

Immunology, Immunodominance, Different Types +16